Toldot Genetics improves healthcare through the use of whole genome sequencing, developing and applying sophisticated algorithm-based tools and approaches to assign genetic variations to clinical conditions.
At Toldot, we believe that the outstanding progress and innovation in the sequencing field can be used right now for many clinical applications and that we can fill the gap that still exists between the sequencing output and actual relevance to healthcare.
Our flagship product, TGex, the NGS Analysis and Interpretation platform, is an end-to-end analysis, interpretation and reporting platform that offers laboratories, diagnostic companies, hospitals and researchers with an “operating system” for their NGS operations.
We are a team of experts with a proven record in combining computer science and molecular biology for reaching novel discoveries in diagnostics and pharmaceuticals.
Genetic institutes can finally offer families with rare genetic disorders a quick and accurate genetic counseling that is based on full sequencing and expert bioinformatic analysis at Toldot Genetics. The best Israeli geneticists have already chosen Toldot for this complex process of pinpointing the causal genetic variation of any disorder they consider as genetic.
The analysis package at Toldot takes the best from the intuition and knowledge of the physician in combination with our vast experience in genomic research, thus markedly increasing the success rates of solving genetic cases.
If you have any genetic concern in your family or you are a physician handling such a matter, feel free to contact us now for any advice.
Pharma and BioTech companies can finally use novel sequencing methods for various applications in their clinical pipelines. The expert team at Toldot Genetics designs and analyzes the sequencing experiments for the specific requirements of the project, incorporating gold-standard tools with in-house algorithms and software.
A service package at Toldot means going hand in hand with the project manager from the initial design of the experiment and all the way to the final report, optimizing the synergy between the your knowledge and expertise and our experience in utilizing these for practical clinical significance. Contact us now with any question and get a free advice regarding your sequencing project.
Dvir Dahary, Co-Founder & CEO
M.Sc. in Cell Research, Tel-Aviv University. Over a decade of experience in genomic research, working with both Biotech companies and research institutes (in Israel, US and Japan) as a researcher, project manager, team leader and freelance consultant. Until recently employed at the Department of Molecular Genetics at the Weizmann Institute as a research consultant, and formerly as a computational biologist at the Research and Development Laboratory of the Genetic Institute at Tel-Aviv Medical Center, Kyowa Hakko Kogyo (Japan) and Compugen Ltd (Israel).
Ami Haviv, Co-Founder & CTO
Ph.D. in Pure Mathematics, Hebrew University. 9 years as member and leader of an IDF elite technology group. Recipient of Israel Defense Prize in 1996. Seven years with Compugen Ltd., last position as Head of Computational Biology group.